Zollinger-ellison Syndrome
📧 Sign up to get email alerts when something new happens for Zollinger-ellison Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-06-16FDA Approved: FAMOTIDINE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves the original Abbreviated New Drug Application for famotidine from Upsher-Smith Laboratories, LLC, granting a generic version of…
-
FDA approval · 2023-06-07FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for esomeprazole magnesium (generic) from Zydus Pharmaceuticals USA Inc. The approval covers the same …
-
FDA approval · 2023-05-22FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved Sun Pharmaceutical Industries' supplemental application for esomeprazole magnesium (generic), a proton pump inhibitor, under th…
-
FDA approval · 2023-05-15FDA Approved: FAMOTIDINE — Original Application (Ascend Laboratories, LLC)
The FDA approved the original ANDA for famotidine from Ascend Laboratories, LLC, enabling a generic version of the H2 blocker to enter the m…
-
FDA approval · 2023-04-28FDA Approved: OMEPRAZOLE — Original Application (Aurohealth LLC)
FDA approved Aurohealth LLC's original ANDA for omeprazole, enabling the marketing of a generic proton pump inhibitor in the United States. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-04-06FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for pantoprazole sodium from Mylan Pharmaceuticals Inc., granting approval of a generic pantopra…
-
FDA approval · 2023-03-08FDA Approved: ESOMEPRAZOLE SODIUM — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for esomeprazole sodium from Gland Pharma Limited, expanding the generic's regulatory approval. The …
-
FDA approval · 2023-02-09FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Ajanta Pharma USA Inc.)
FDA approved Pantoprazole Sodium as an original generic product (ANDA 217416) for Ajanta Pharma USA Inc., expanding access to pantoprazole s…
-
FDA approval · 2022-11-01FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole, Wal-Mart's store-brand lansoprazole. The approval confirms the Wal-Mart Sto…
-
FDA approval · 2022-09-30FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA granted a supplemental approval for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen.
-
FDA label_change · 2022-09-27FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for pantoprazole sodium from Sun Pharmaceutical Industries, resulting in an updated labeling for the…
-
FDA approval · 2022-08-29FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Northstar Rx LLC)
FDA approved Pantoprazole sodium as an original ANDA for a generic product manufactured by Northstar Rx LLC.
-
FDA approval · 2022-08-15FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for pantoprazole filed by NorthStar RxLLC.
-
FDA approval · 2022-07-28FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for pantoprazole sodium from Eugia US LLC. The action pertains to an already approved generic, t…
-
FDA approval · 2022-06-24FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for esomeprazole magnesium as a generic proton pump inhibitor manufactured by Rising Pharma Holdings, Inc.
-
FDA approval · 2022-06-09FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for pantoprazole sodium from Lannett Company, enabling the marketing of this generic proton pump inh…
-
FDA approval · 2022-06-09FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for pantoprazole sodium from NorthStar Rx LLC, a generic pantoprazole product.
-
FDA approval · 2022-06-03FDA Approved: FAMOTIDINE — Original Application (Zydus Lifesciences Limited)
The FDA approved an original abbreviated new drug application (ANDA) for famotidine from Zydus Lifesciences Limited, making a generic versio…
-
FDA approval · 2022-05-19FDA Approved: PANTOPRAZOLE SODIUM I.V. — Original Application (Piramal Critical Care)
FDA approved Pantoprazole sodium for injection (IV) from Piramal Critical Care under an original application.
-
FDA approval · 2022-05-18FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Novadoz Pharmaceuticals LLC)
The FDA approved Pantoprazole sodium from Novadoz Pharmaceuticals LLC under an Original Application (ANDA216171), adding a generic pantopraz…
-
FDA approval · 2022-05-18FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' pantoprazole sodium as an original ANDA generic product. It is indicated for GERD-related conditions su…
-
FDA approval · 2022-03-04FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Omeprazole submitted by Apotex Corp.
-
FDA approval · 2022-03-04FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for a generic omeprazole product from Lannett Company, Inc.
-
FDA approval · 2022-03-04FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX I.V. (pantoprazole sodium), adding an intravenous formulation under Wyeth/Pfizer to exp…
-
FDA approval · 2022-03-04FDA Approved: OMEPRAZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's supplemental application for omeprazole, a generic proton pump inhibitor, expanding or updating its approval for…